Skip to main content.

Hartmut Jaeschke, PhD, ATS, FAASLD

Hartmut Jaeschke portrait
University Distinguished Professor, Pharmacology, Toxicology & Therapeutics

Department Chair, SOM-Kansas City, Pharmacology, Toxicology & Therapeutics

Professional Background

Hartmut Jaeschke, PhD, ATS, FAASLD, is University Distinguished Professor and Chairman of the Department of Pharmacology, Toxicology, and Therapeutics at the University of Kansas Medical Center, Kansas City, Kansas. He joined KUMC in 2006. He is a Fellow of the Academy of Toxicological Sciences (ATS) and Fellow of the American Association for the Study of Liver Diseases (FAASLD). After receiving his Ph.D. degree in toxicology from the University of Tübingen, Germany, in 1983, he did postdoctoral work at the University of Tübingen and at Baylor College of Medicine in Houston, Texas, USA. Since 1987, he held faculty positions at Baylor (1987–1992), at the University of Arkansas for Medical Sciences, Little Rock, (1999–2002), and at the University of Arizona, Tucson (2002–2006). In addition, he spent 6 years in the pharmaceutical industry (The Upjohn Co. and Pharmacia andamp; Upjohn Co., Kalamazoo, MI), from 1992 to 1998. He has published more than 470 peer-reviewed manuscripts, invited reviews, and book chapters in the areas of liver toxicology and liver pathophysiology (“h-factor 115”; >51,000 citations - Google Scholar). Dr. Jaeschke was a standing member of the Hepatobiliary Pathophysiology NIH study section (2008-2013) and served as ad-hoc member on numerous additional NIH grant review committees. In the past, Dr. Jaeschke served on the Editorial Boards of Hepatology, American Journal of Physiology: Liver and Gastrointestinal Physiology, Gastroenterology and Journal of Hepatology; he was an Associate Editor for Hepatology (2002–2006) and Liver International (2007–2012). He currently serves as Associate Editor for Toxicological Sciences (since 2014) and 4 other journals; in addition, he is inaugural Editor-in-Chief of Livers (since 2020) and member of 14 editorial boards. In 2019, he was the recipient of the Translational Impact Award from the Society of Toxicology. His major research interests include basic mechanisms and translational aspects of xenobiotic-induced hepatotoxicity and tissue repair with focus on acetaminophen overdose and mechanisms of inflammatory liver injury in animal models and humans.

Education and Training
  • MSC, Diplombiochemiker (Biochemistry), University of Tübingen, Tübingen, Germany
  • PhD, Toxicology, University of Tübingen, Tübingen, Germany